Amgen ends 2 trials of pancreatic cancer drug
04:36 EDT 9 Aug 2012 | SmartBrief
Amgen stopped a Phase III study of pancreatic cancer drug candidate AMG479, or ganitumab, after reviewers said it is unlikely -More-
Original Article: Amgen ends 2 trials of pancreatic cancer drug
More From BioPortfolio on "Amgen ends 2 trials of pancreatic cancer drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
